Pfizer, Inc. Stock

Equities

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse 04:00:39 2024-04-23 pm EDT 5-day change 1st Jan Change
26.32 USD +0.23% Intraday chart for Pfizer, Inc. +2.45% -8.58%
Sales 2024 * 59.96B Sales 2025 * 62.57B Capitalization 149B
Net income 2024 * 6.75B Net income 2025 * 9.29B EV / Sales 2024 * 3.26 x
Net Debt 2024 * 47.04B Net Debt 2025 * 41.91B EV / Sales 2025 * 3.05 x
P/E ratio 2024 *
19.3 x
P/E ratio 2025 *
14 x
Employees 88,000
Yield 2024 *
6.46%
Yield 2025 *
6.62%
Free-Float 59.09%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.02%
1 week+2.45%
Current month-5.15%
1 month-4.05%
3 months-7.42%
6 months-14.66%
Current year-8.58%
More quotes
1 week
25.23
Extreme 25.23
26.50
1 month
25.23
Extreme 25.23
28.12
Current year
25.23
Extreme 25.23
30.28
1 year
25.23
Extreme 25.23
40.37
3 years
25.23
Extreme 25.23
61.71
5 years
25.23
Extreme 25.23
61.71
10 years
25.23
Extreme 25.23
61.71
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 92-12-31
Director of Finance/CFO 59 22-05-01
Chief Tech/Sci/R&D Officer - 19-06-30
Members of the board TitleAgeSince
Director/Board Member 66 20-03-31
Director/Board Member 64 17-02-22
Director/Board Member 60 13-09-26
More insiders
Date Price Change Volume
24-04-22 26.26 +1.00% 35,678,657
24-04-19 26 +2.40% 38,372,801
24-04-18 25.39 -0.12% 35,788,351
24-04-17 25.42 -1.05% 43,828,892
24-04-16 25.69 -0.85% 28,885,313

Delayed Quote Nyse, April 23, 2024 at 04:00 pm EDT

More quotes
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
26.26 USD
Average target price
31.62 USD
Spread / Average Target
+20.41%
Consensus